CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash provided by (used in) operating activities
Net income	$ 17,936	$ 1,951
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Amortization of intangible assets	1,309	1,598
Depreciation	2,925	3,532
Stock-based compensation expense	132	315
Amortization of financing fees	938	1,730
Deferred income taxes	131	25
Provision for losses in accounts receivable	2,998	(305)
Increase in allowance for inventory obsolescence	2,560	423
Other adjustments, net	3	465
Changes in operating assets and liabilities:
Accounts receivable	15,476	(17,318)
Inventory	23,611	14,548
Prepaid expenses, right-of-use assets and other assets	(5,641)	(6,289)
Accounts payable	(1,268)	(20,186)
Income taxes receivable	0	3,710
Accrued expenses	2,638	7,802
Other noncurrent liabilities	(1,631)	(9,708)
Net cash provided by (used in) operating activities	62,117	(17,707)
Cash used in investing activities
Capital expenditures	(2,678)	(991)
Net cash used in investing activities	(2,678)	(991)
Cash (used in) provided by financing activities
Repayment of debt	(50,000)	0
Repayment of long-term debt and lease liabilities	(161)	(203)
Proceeds from short-term financings	0	31,582
Repayment of short-term financings	(593)	(581)
Payments of deferred financing costs	(983)	(1,787)
Other financing activities, net	(2)	(3)
Net cash (used in) provided by financing activities	(51,739)	29,008
Net increase in cash, cash equivalents, and restricted cash	7,700	10,310
Cash, cash equivalents, and restricted cash at beginning of the period	27,900	9,732
Cash, cash equivalents, and restricted cash at end of the period	35,600	20,042
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheets
Cash and cash equivalents	31,793	16,477
Restricted cash	3,807	3,565
Total cash, cash equivalents, and restricted cash	$ 35,600	$ 20,042